Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: Case report and review of literature

International Journal of Hematology

Volumn 95, Issue 1, 2012, Pages 102-106

  Muzaffar, Jameel ^a   Katragadda, Lakshmikanth ^a   Haider, Sajjad ^a   Javed, Ali ^a   Anaissie, Elias ^a   Usmani, Saad ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Acquired hemophilia; Bleeding; Factor VIII inhibitor; Multiple myeloma

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 INHIBITOR; BORTEZOMIB; DEXAMETHASONE; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; RITUXIMAB; THALIDOMIDE;

ACQUIRED FACTOR VIII INHIBITOR; AGED; BLOOD CLOTTING DISORDER; CASE REPORT; CONFERENCE PAPER; HEART TAMPONADE; HEMARTHROSIS; HEMOPERICARDIUM; HUMAN; KIDNEY FAILURE; MALE; MULTIPLE MYELOMA; PERICARDIAL EFFUSION; PERICARDIOCENTESIS;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; AUTOANTIBODIES; BLOOD COAGULATION FACTORS; DRUG THERAPY, COMBINATION; FACTOR VIII; HEMARTHROSIS; HEMOPHILIA A; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; MULTIPLE MYELOMA; PERICARDIAL EFFUSION; SEVERITY OF ILLNESS INDEX;

EID: 84857630273     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0968-7     Document Type: Conference Paper

References (18)

1. PA Holme F Brosstad GE Tjonnford 2005 Acquired hemophilia: management of bleeds and immune therapy to eradicate autoantibodies Haemophilia 11 510 515 16128896 10.1111/j.1365-2516.2005.01136.x 1:CAS:528:DC%2BD2MXhtFSisrnL (Pubitemid 41283121)
2. M Franchini G Lippi 2007 Acquired von Willebrand syndrome: an update Am J Hematol 82 368 375 17133419 10.1002/ajh.20830 1:CAS:528:DC%2BD2sXlsVKqsLk%3D (Pubitemid 46651140)
3. I Sari MA Erkut A Ifran, et al. 2009 Multiple myeloma presenting with acquired factor VIII inhibitor Int J Hematol 90 166 169 19551464 10.1007/s12185-009-0363-9
4. S Sallah NP Nguyen JM Abdallah LR Hanrahan 2000 Acquired hemophilia in patients with hematologic malignancies Arch Pathol Lab Med 124 5 730 734 10782157 1:STN:280:DC%2BD3c3ksFWktA%3D%3D (Pubitemid 30321878)
5. RB Stricker B Barlogie DD Kiprov 1994 Acquired factor VIII inhibitor associated with chronic Interferon-alpha therapy J Rheumatol 21 350 352 8182649 1:STN:280:DyaK2c3jvVGrtg%3D%3D (Pubitemid 24078853)
6. HI Glueck R Hong 1965 A circulating anticoagulant in gamma-1A-multiple myeloma: its modification by penicillin J Clin Invest 44 1866 1881 5843717 10.1172/JCI105294 1:CAS:528:DyaF28XmtVSm
7. A Huth-Kuhne F Baudo P Collins J Ingerslev, et al. 2009 International recommendations on the diagnosis and treatment of patients with acquired Hemophilia A Haematologica 94 566 575 19336751 10.3324/haematol.2008.001743
8. C Negrier J Goudemand Y Sultan, et al. 1997 Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor eight bypassing activity Thromb Haemost 77 1113 1119 9241742 1:CAS:528:DyaK2sXksFKlurk%3D (Pubitemid 27311979)
9. TT Yee A Taher KJ Pasi, et al. 2000 A survey of patients with acquired hemophilia in a hemophilia centre over a 28 year period Clin Lab Haematol 22 275 278 11122268 10.1046/j.1365-2257.2000.00316.x 1:STN:280: DC%2BD3M%2FpsV2hug%3D%3D (Pubitemid 32047101)
10. MJ Sumner BD Geldziler M Pedersen S Seremetis 2007 Treatment of acquired hemophilia with recombinant activated FVII: a critical appraisal Haemophilia 13 451 461 17880429 10.1111/j.1365-2516.2007.01474.x 1:CAS:528:DC%2BD2sXhtFCksrnP (Pubitemid 47337982)
11. CR Hay C Negrier CA Ludlum 1997 The treatment of bleeding in acquired hemophilia with recombinant factor VIIa: a multicenter study Thromb Haemost 78 1463 1467 9423795 1:CAS:528:DyaK2sXnvVKgsrw%3D (Pubitemid 27519390)
12. J Delgado V Jimenez-Yuste F Hernandez-Navarro A Villar 2003 Acquired hemophilia: review and meta-analysis focused on therapy and prognostic factors Br J Haematol 121 21 35 12670328 10.1046/j.1365-2141.2003.04162.x 1:CAS:528:DC%2BD3sXjsVaksbc%3D (Pubitemid 36461264)
13. PW Collins S Hirsch TP Baglin G Dolan, et al. 2007 Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation Blood 109 1870 1877 17047148 10.1182/blood-2006-06-029850 1:CAS:528:DC%2BD2sXjtFeqt7Y%3D (Pubitemid 46348182)
14. YW Huang P Saidi C Philipp 2004 Acquired Factor VIII inhibitors in non-hemophiliac patients: clinical experience of 15 cases Haemophilia 10 713 721 15569166 10.1111/j.1365-2516.2004.01031.x (Pubitemid 40028587)
15. AC Dykes ID walker GD Lowe RC Tait 2001 Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2 year review Haemophilia 7 2 160 163 11260275 10.1046/j.1365-2516.2001.00489.x 1:CAS:528:DC%2BD3MXnsFWgu78%3D (Pubitemid 32243798)
16. R Stasi M Brunetti E Stipa, et al. 2004 Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia Blood 103 12 4424 4428 14996701 10.1182/blood-2003-11-4075 1:CAS:528:DC%2BD2cXlt1KrsLc%3D (Pubitemid 38745966)
17. WR Sperr K Lechner I Pabinger 2007 Rituximab for the treatment of acquired antibodies to factor VIII Haematologica 92 66 71 17229637 10.3324/haematol.10553 1:CAS:528:DC%2BD2sXitlOrtL0%3D (Pubitemid 46232659)
18. RS Schwartz DA Gabriel LM Aledort D Green CM Kessler 1995 A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high dose intravenous gammaglobulin Blood 86 797 804 7606010 1:CAS:528: DyaK2MXmvVygsr0%3D